EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Time to Progression of Prostate Cancer on Androgen Deprivation Therapy and Response Correlation with Gleason Score and PSA Value

Krestiyan Manuail, Jang Muhialdin, Fahmi Salih

Advanced Medical Journal · 2026-09-04 · 11 (3) · 287-296

DOI: 10.56056/amj.2026.512 ↗
AbstractBibliografische Angaben

Abstract

Background and Objectives: Prostate cancer progression is influenced by Gleason scores and prostate-specific antigen levels. This study aims to find the association between these markers and the duration until disease progression in patients undergoing androgen deprivation therapy. Methods: This retrospective cohort study included 108 patients with prostate cancer treated at Nanakali Hospital and Rizgary Teaching Hospital in Erbil, Iraq. Data on demographics, clinical variables (prostate-specific antigen levels, the lowest prostate-specific antigen level reached after initiation of androgen deprivation therapy, Gleason score, and time to disease progression), and sites of metastasis were collected. Results: Patients with metastatic disease had higher initial prostate-specific antigen levels (median 102 nanograms per deciliter) compared to non-metastatic patients (median 20.5 nanograms per deciliter, p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →